story of the week
Primary Prevention of CV and HF Events With SGLT2i, GLP-1RA, and Their Combination in T2D
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
Diabetes Care 2022 Jan 31;[EPub Ahead of Print], AK Wright, MJ Carr, E Kontopantelis, L Leelarathna, H Thabit, R Emsley, I Buchan, MA Mamas, TP van Staa, N Sattar, DM Ashcroft, MK RutterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.